Listen to this article

Little Falls-based Cantel Medical Corp. announced on Tuesday that it has acquired PuriCore International Limited, a wholly-owned subsidiary of PuriCore plc. Financial terms of the deal were not disclosed.

The transaction provides Cantel Medical with additional resources, like automated endoscope reprocessing, and capabilities for its global strategy.

PuriCore International Limited will be renamed Cantel Medical (UK) Limited, and will be part of the company’s endoscopy segment.

PuriCore currently has approximately 120 employees throughout Stafford and Clevedon, England.  The acquisition provides Cantel coverage in the UK market.

“This acquisition is an exciting step in the execution of our international strategy,” Jorgen Hansen, president of Medivators and COO of Cantel Medical, said in a news release.  “The addition of the PuriCore endoscopy business to Medivators will meaningfully strengthen our offering in automated endoscope reprocessing while also enhancing our international capabilities and competitiveness.  We are excited to welcome the entire PuriCore International workforce to the Cantel family, and we look forward to working together toward delivering infection prevention and control solutions to patients and customers worldwide.”

ALSO ON NJBIZ:

The next step: Jersey City mayor Steven Fulop sets his sights on year two, while others ponder his future

Big Ten, big bucks: Rutgers’ conference switch brings more revenue opportunities (A Q&A with Julie Hermann, Rutgers’ athletic director)

Jerseyans react after Supreme Court sides with Hobby Lobby in ACA case, saying private businesses do not have to offer contraception services